Vaccination against COVID-19 is crucial for individuals with multiple sclerosis (MS), ensuring safety and effectiveness despite immunosuppressive therapies.

The medicines regulator has issued a warning to NHS health staff about a small increased risk of a rare condition affecting the nerves in people vaccinated against respiratory syncytial virus (RSV).

New research shows COVID-19 raises the risk of Guillain-Barré syndrome more than vaccines. mRNA vaccines pose no increased risk, global data reveals.

More information: Sharifa Nasreen et al, Risk of Guillain-Barré syndrome after COVID-19 vaccination or SARS-CoV-2 infection: A multinational self-controlled case series study, Vaccine (2025).

As it advances a monoclonal antibody targeting Guillain-Barré syndrome (GBS), Annexon Biosciences is embarking on another effort to improve treatment of the rare condition. | As it advances a ...

Autoimmune chaos: An unhealthy gut might be fuelling deadly nerve attacks. Here are diet tips to reduce the risk of Guillain-Barré Syndrome naturally.

What are the risk factors for GBS? The exact cause of Guillain-Barré Syndrome is unknown, but several factors can increase the risk of developing it.

Reduce risk of developing Guillain Barre Syndrome (GBS) with these 9 neurologist-approved steps Despite taking all the precautions, if you develop symptoms of GBS, do not panic, Dr Sudhir Kumar ...

Tingling, weakness of hand-grip or foot drop could signal Guillain-Barré Syndrome (GBS), said health experts on Monday, even as the reported cases spike to over a hundred in Pune, Maharashtra ...

What is Guillain-Barre Syndrome? Dr Nikhil Prasun, head of Neurology at Manipal Broadway Hospital, Kolkata, explained: “Guillain-Barré syndrome refers to a disease pertaining to the peripheral nervous ...